Category Biology/Biotechnology

Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem. The microbial ecosystem (or microbiome) of the human respiratory tract colonizes different niches. The respiratory tract microbiome is of interest to scientists as it contributes to human health by stimulating the immune system and protecting against infection by pathogens. Scientists from the Institut Pasteur and the CNRS have demonstrated that the microbiome composition, pathogen load and clinical interventions influence the severity of bacterial pneumonia caused by Legionella pneumophila...

Vibrant green leaves sprout from tall fragrant plants sitting neatly in two rows of terracotta pots in Valerie Sponsel’s UTSA biology laboratory. One floor just above her is the chemistry lab of Francis Yoshimoto, who is extracting the plant’s leaves for medicinal compounds. Soon, the researchers will meet with UTSA researcher Annie Lin, who will test the extracted compounds on cancer cells.

The plant is Artemisia annua, or Sweet Annie, and it contains medicinal compounds. UTSA researchers are studying the plant to understand the bioactive properties of one of these compounds, Arteannuin B, in cancer cells and COVID, the disease caused by the virus, SARS-CoV-2.

“Around 50% of prescription drugs are derived from natural products. They’re made by plants, fungi or bacteria...

Researchers have unveiled an intriguing phenomenon of cellular reprogramming in mature adult organs, shedding light on a novel mechanism of adaptive growth. The study, which was conducted on fruit flies (Drosophila), provides further insights into dedifferentiation — where specialized cells that have specific functions transform into less specialized, undifferentiated cells like stem cells.

Until now, dedifferentiation has primarily been associated with severe injuries or stressful conditions, observed during tissue regeneration and diseases like tumorigenesis...

In a breakthrough for the field of bioelectronics, researchers at EPFL have enhanced the ability of E. coli bacteria to generate electricity. The innovative approach offers a sustainable solution for organic waste processing while outperforming previous state-of-the-art technologies, opening new horizons for versatile microbial electricity production.

“We engineered E. coli bacteria, the most widely studied microbe, to generate electricity,” says Professor Ardemis Boghossian at EPFL. “Though there are exotic microbes that naturally produce electricity, they can only do so in the presence of specific chemicals. E...